I haven’t seen a doctor in eight years. I haven’t filed a medical insurance claim, sat in a waiting room, or let a corporate algorithm check my vitals since Obama was in office. I am 70 years old. I know the body grows older, and I know I won’t live forever. But like generations before me, I would much rather place what’s left of my days into the hands of God than into the gears of an all-in-for-profit medical-industrial machine.

The machine, however, does not like to be ignored.

Some weeks ago, a delivery truck pulled into my driveway. The driver walked up to my porch and dropped off a heavy, pristine, beautifully engineered cardboard box. Inside was a specialized medical bucket, complete with collection straps, sterile vials, chemical preservatives, and an explicit set of instructions on how I could donate my daily biological waste to Wall Street.

I didn’t ask for it. No doctor who knows my name prescribed it. But to the massive corporate entities that traded the test-maker Exact Sciences to Abbott Laboratories for a staggering $23 billion, I am not a person. I am a dormant, unmined raw-material supplier.

Elon Musk famously tells a joke about two economists who pay each other $100 to eat a pile of waste, proving that you can artificially pump up the Gross Dependent Product (GDP) through meaningless, unpleasant transactions. But healthcare executives didn’t laugh at that joke; they used it as a business plan. They realized that if you can convince a 70-year-old to package their waste and mail it across the country, you can ignite a multi-industry financial value chain where everybody wins—except the person holding the bucket.

Let us map out the brilliant, cynical architecture of the Ecosystem of the Bucket, and see exactly who gets paid the moment that box hits a porch:

Before a single scientist or lab technician looks at a sample, the shipping industry has already won. Moving millions of these heavy, biohazard-compliant boxes across the country creates an incredibly lucrative, recurring contract for commercial shipping giants.

The diagnostic company pays massive commercial fees to mail the heavy, empty plastic kit out to a 70-year-old’s house, and pays an even higher premium for expedited, temperature-sensitive return shipping. If I ignore the box and throw it in the trash, the shipping company still keeps their money. The transaction itself is the profit.

The bucket isn’t just an ordinary container; it requires a highly specific, medical-grade manufacturing process. Specialized injection-molding factories and chemical preservation companies are contracted to mass-produce millions of these kits annually. They don’t care about colorectal cancer statistics. They care about high-volume plastic production. They get paid upfront just for supplying the plastic seats, collection tubes, and preservatives—completely insulated from whether a patient ever actually uses it.

To scale a multi-billion-dollar business, you cannot wait for patients to schedule an appointment with a local family doctor. That creates a bottleneck. Instead, massive test-makers partner with outsourced, third-party telehealth networks or national pharmacy chains to integrate screening tools directly into corporate workflows.

Somewhere in a distant data center, an automated algorithm flagged my birth year, generated a digital signature, and had a remote medical professional—who has never met me, spoken to me, or read my medical history—click “approve” on a mass prescription file. That digital click triggers a consultation fee, keeping a massive network of remote medical professionals financially fed.

The at-home bucket carries a hefty list price of around $600. But the bucket isn’t the ultimate destination; it is a front-end marketing funnel designed to feed the much larger, more expensive back-end system.

If a 70-year-old returns the bucket and the highly sensitive test flags a potential marker—even a false positive—the patient is legally and clinically funneled directly into a full diagnostic colonoscopy. A colonoscopy requires an outpatient surgery center, an anesthesiologist, a gastroenterologist, and a pathology lab. By sending a “free” or insurance-covered box to my porch, the corporate structure attempts to turn an independent citizen into a subsequent $3,000 to $5,000 multi-provider transaction loop.

When you strip away the clean, corporate language of “preventative population health,” you see the system for what it frequently is: a highly aggressive transaction engine looking for any raw material to convert into a corporate asset. They have literally figured out how to commoditize human waste, and they are using it to rope independent people back into a system they chose to leave years ago.

The machine wants us to believe that our security, our future, and our days are governed by diagnostic metrics, corporate check-boxes, and plastic buckets delivered to our doorsteps.

But at 70 years old, after eight years of peace away from their waiting rooms, I look at that box on my porch and realize something the executives on Wall Street will never understand: there are some things in this life that cannot be financialized, and there is a profound dignity in choosing to trust the Creator with what’s left, rather than surrendering your peace to an industry that sees your body as nothing more than a quarterly revenue target.